Interim Analysis of Key Clinical Outcomes from a Phase 1/2 Study of Weekly Intravenous DNL310 (Brain-Penetrant Enzyme Replacement Therapy) in MPS II
Molecular Genetics and Metabolism(2024)
Key words
Mucopolysaccharidoses,Enzyme Replacement Therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined